ICU · Resuscitation
Blood transfusion in the ICU
Also known as Transfusion thresholds · Restrictive vs liberal transfusion · TRICC trial · TRISS trial · REALITY trial · Transfusion reactions · TRALI and TACO · Massive transfusion ratio 1:1:1 · PROPPR trial · Blood product administration · Transfusion-associated circulatory overload · Transfusion-related acute lung injury
The TRICC trial (1999) established that a RESTRICTIVE transfusion strategy (transfuse at Hb <70 g/L) is at least as effective as and possibly superior to a liberal strategy in most ICU patients, with the possible exception of acute MI and unstable angina. Restrictive strategies cut blood exposure and transfusion-hazard risk — TACO is the leading cause of transfusion-related death. Populations tested: acute MI (REALITY — restrictive trigger Hb ≤8 non-inferior for MACE), cardiac surgery (TRICS III — restrictive non-inferior), hip fracture surgery (FOCUS — liberal no better), septic shock (TRISS — restrictive non-inferior with median 1 vs 4 units), paediatric ICU (TRIPICU). Acute brain injury/TBI: debated, no trial-proven higher threshold. Single unit transfusion (one at a time, reassess, equilibration ~24 h) is standard. Transfusion reactions: TRALI (ARDS-type within hours, supportive care), TACO (volume overload, diuretic, leading cause of transfusion-related death), allergic, anaphylactic (anti-IgA), acute haemolytic (ABO mismatch), delayed haemolytic, febrile non-haemolytic, bacterial contamination (room-temperature platelets), transfusion-associated GVHD (irradiation prevents; leukoreduction does not). Blood products: PRBC, FFP, platelets, cryoprecipitate, PCC. Massive transfusion: balanced 1:1:1 ratios (PROPPR — more haemostasis, fewer exsanguination deaths), early TXA (CRASH-2), calcium for citrate hypocalcaemia.
Practise this topic
On this page
Study tools
Your progress
Saved on this device.
Target exams
Red flags
- Restrictive strategy (Hb <70) is safe in MOST ICU patients — do NOT transfuse above 70 without indication
- TRALI (transfusion-related acute lung injury): new hypoxia + bilateral infiltrates within hours of transfusion — stop transfusion, supportive care, no diuretics
- TACO (transfusion-associated circulatory overload): pulmonary oedema from volume — the leading cause of transfusion-related death; give diuretics
- ABO-incompatible transfusion: STOP immediately — potentially fatal haemolytic reaction
- Anaphylaxis to transfusion: IgA-deficient recipient with anti-IgA — adrenaline per anaphylaxis protocol
- Transfusion-associated GVHD: rare but usually fatal — irradiate cellular products for immunocompromised recipients (leukoreduction is not sufficient)
- Bacterial contamination of platelets (stored at room temperature): fever + shock during or soon after transfusion — cultures of patient AND unit, broad-spectrum antibiotics
- Massive transfusion with hypocalcaemia: citrate in transfused products chelates Ca2+ — give IV calcium guided by ionised calcium
Meet the patient
A 72-year-old with pneumonia and septic shock has a haemoglobin of 78 g/L. The foundation doctor has prescribed two units to bring the Hb above 100. The question is whether that unit in the fridge should ever leave it.[1]
The one decision that governs every ICU transfusion is the threshold: restrictive (Hb under 70) is safe in nearly every population tested, and each unnecessary unit adds avoidable risk — TACO alone affects roughly two of every thousand components transfused and is the leading cause of transfusion-related death. Hold that line, and the six reaction windows below slot into place.[1][14]
References22ShowHide
- [1]Hébert PC, Wells G, Blajchman MA, et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group N Engl J Med, 1999.PMID 9971864
- [2]Holst LB, Haase N, Wetterslev J, et al. Lower versus higher hemoglobin threshold for transfusion in septic shock N Engl J Med, 2014.PMID 25270275
- [3]Carson JL, Grossman BJ, Kleinman S, et al. Red blood cell transfusion: a clinical practice guideline from the AABB* Ann Intern Med, 2012.PMID 22751760
- [4]Holcomb JB, Tilley BC, Baraniuk S, et al. Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma: the PROPPR randomized clinical trial JAMA, 2015.PMID 25647203
- [5]Ducrocq G, Gonzalez-Juanatey JR, Puymirat E, et al. Effect of a Restrictive vs Liberal Blood Transfusion Strategy on Major Cardiovascular Events Among Patients With Acute Myocardial Infarction and Anemia: The REALITY Randomized Clinical Trial JAMA, 2021.PMID 33560322
- [6]Mazer CD, Whitlock RP, Fergusson DA, et al. Six-Month Outcomes after Restrictive or Liberal Transfusion for Cardiac Surgery N Engl J Med, 2018.PMID 30146969
- [7]Carson JL, Terrin ML, Noveck H, et al. Liberal or restrictive transfusion in high-risk patients after hip surgery N Engl J Med, 2011.PMID 22168590
- [8]Vlaar APJ, Toy P, Fung M, et al. A consensus redefinition of transfusion-related acute lung injury Transfusion, 2019.PMID 30993745
- [9]Shakur H, Roberts I, Bautista R, et al. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial Lancet, 2010.PMID 20554319
- [10]Roberts I, Shakur H, Afolabi A, et al. The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial Lancet, 2011.PMID 21439633
- [11]Soutar R, McSporran W, Tomlinson T, et al. Guideline on the investigation and management of acute transfusion reactions Br J Haematol, 2023.PMID 37211954
- [12]Heyes J, Kelly PA, Monaghan K, et al. A single unit transfusion policy reduces red cell transfusions in general medical in-patients QJM, 2017.PMID 29024964
- [13]Bosboom JJ, Klanderman RB, Migdady Y, et al. Transfusion-Associated Circulatory Overload: A Clinical Perspective Transfus Med Rev, 2019.PMID 30853167
- [14]White SK, Walker BS, Potter S, et al. Estimating the incidence of transfusion-associated circulatory overload using active surveillance: A systematic review and meta-analysis Transfusion, 2025.PMID 40342068
- [15]Zhou L, Giacherio D, Cooling L, et al. Use of B-natriuretic peptide as a diagnostic marker in the differential diagnosis of transfusion-associated circulatory overload Transfusion, 2005.PMID 15987348
- [16]Agarkar R, Kesharwani R, Nagpal S, et al. Hemoglobin equilibration kinetics after single-unit red blood cell transfusion in stable hospitalized adults: A prospective cohort study Transfus Apher Sci, 2026.PMID 42048991
- [17]Alghanem H, Liu NC, Gupta A, et al. Ratios of calcium to citrate administration in blood transfusion for traumatic hemorrhage: A retrospective cohort study Transfusion, 2024.PMID 39351914
- [18]Corwin HL, Gettinger A, Fabian TC, et al. Efficacy and safety of epoetin alfa in critically ill patients N Engl J Med, 2007.PMID 17804841
- [19]Lacroix J, Hébert PC, Hutchison JS, et al. Transfusion strategies for patients in pediatric intensive care units N Engl J Med, 2007.PMID 17442904
- [20]Rodriguez JV, Tormey CA Can transfusion-associated graft-versus-host disease (TA-GvHD) be prevented with leukoreduction alone? Transfus Apher Sci, 2022.PMID 35288056
- [21]Jacobs MR, Zhou B, Tayal A, et al. Bacterial Contamination of Platelet Products Microorganisms, 2024.PMID 38399662
- [22]Leentjens J, Middeldorp S, Jung C, et al. A short review of ciraparantag in perspective of the currently available anticoagulant reversal agents Drug Discov Today, 2022.PMID 35933085